Left ventricular ejection fraction and mortality | |
---|---|
LVEF | death |
≤15% | 51% |
16-25% | 41.7% |
26-35% | 31.4% |
35-45% | 25.6% |
Diabetes
Type 2 diabetes is a factor that increases the risk of poor prognosis in CHF patients. Studies have shown that people with diabetes are two to four times more likely to develop CHF than people without diabetes. Among heart failure patients, 47% also have diabetes. And many people with CHF have diabetes, which goes undetected and undiagnosed.
The study of 150 patients with heart failure evaluated previously undiagnosed prediabetes and type 2 diabetes. Of this group, 43% were found to be prediabetic and 19% were diabetic.
During a two-year follow-up, compared to people without prediabetes or diabetes, people with prediabetes were 2.6 times more likely to die from any cause and more likely to die from cardiovascular causes such as heart attack or stroke. The sex was almost three times as high. or worsening of heart failure. People with diabetes were more than five times as likely to die from any cause and nearly 10 times as likely to die from cardiovascular disease.
hospitalization
Heart failure requiring hospitalization is associated with poor prognosis. People who are hospitalized multiple times often have other serious medical conditions and are at increased risk of death, especially from cardiovascular disease.
what you can do
Some risk factors for heart failure (such as age) cannot be changed. Still, patients with CHF can take steps to improve their long-term prognosis. The first thing you should do is familiarize yourself with your family history of heart disease. You should also learn about all possible symptoms. Don’t ignore symptoms that may be cause for concern. Tell your health care provider right away.
Regular exercise and managing other health issues can also help control CHF.
exercise
If you have been diagnosed with heart disease, simply losing weight will not reduce your risk of death. Still, continued and sustained physical activity can lead to some degree of risk reduction.
Data analysis from the Heart Failure Adherence and Maintenance Trial compared patients with heart failure who engaged in at least 150 minutes of moderate activity per week or at least 75 minutes of vigorous activity per week (the “ideal” group) to patients with heart failure. was held. little (“intermediate”), or moderate or no vigorous activity (“poor”).
At 2.4 years of follow-up, compared to the ideal group, the other group was almost twice as likely to be hospitalized and more than four times as likely to die from cardiovascular causes. The middle group was twice as likely to die from any cause, and the poor group was almost three times as likely to die from any cause.
2018 study published in Current Obesity Report Sustained weight loss of 5% or more of total body weight has been suggested to improve blood sugar control and reduce the risk of heart-related factors. Healthy lifestyle choices such as diet and exercise can help. The same goes for medications and surgeries for weight management. Always consult your health care provider before starting any weight loss program.
diabetes management
Diabetes is associated with risk of heart failure. Among people with diabetes, 25% have chronic heart failure and up to 40% have acute heart failure. For this reason, people with both diabetes and heart failure are treated by a cardiologist (cardiologist). Good blood sugar control is important to reduce the risk of death.
angiotensinAlpha-converting enzyme (ACE) inhibitors are commonly used to treat both type 1 and type 2 diabetes associated with heart failure. ACE inhibitors have many benefits, leading to lower mortality and fewer hospitalizations. Angiotensin II receptor antagonists (ARBs) have shown similar efficacy in heart failure patients with and without diabetes.
medicine
with heart failure decreased ejection fraction, several drugs have been shown to reduce death and hospitalization. Your health care provider may prescribe a combination of the following drugs:
- Beta-blockers (carvedilol, metoprolol succinate, or bisoprolol)
- Entresto (sacubitril and valsartan)
- ARB or ACE inhibitor
- spironolactone
- Sodium glucose cotransporter 2 (SGLT2) inhibitor
- Ivabradine
with heart failure preserved ejection fractionwith the exception of diuretics, no drugs have been shown to improve mortality. There is some evidence that spironolactone may also have benefits.
The prognosis of heart failure has improved thanks to new drug treatments. Still, the effects of these drugs can change over time. Tell your cardiologist about any new or worsening symptoms. They can evaluate you for possible changes in your treatment.
summary
The left ventricle is the chamber of the heart that pumps blood into the body. When it stops working properly, the amount of blood pumped into the body is not enough to meet your needs.
This can occur because the heart muscle is too weak, causing what is called a reduced ejection fraction. It can also occur because the muscles become stiff and unable to relax, similar to when the ejection fraction is preserved.
These minutes are used to measure how well your heart is working. Along with other factors such as age and other health problems, these can help assess how severe or advanced your girlfriend’s CHF is. This helps your health care provider give you the most accurate estimate possible about the progression of your disease and how much life you have left.
A word from Berrywell
Although the prognosis for CHF may seem discouraging, lifestyle changes and medications can help. These slow the progression of CHF and increase the chances of survival. You can be proactive by monitoring your symptoms and putting aside unhealthy habits. Regular exercise and a healthy diet can help.